UNSPSC 51285504: Fusidate or fusidic acid

This classification denotes a protein synthesis inhibitor and antimicrobial solution with the molecular formula C31H48O6, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 59XE10C19C, chemically known as 29-nordammara-17 (20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, (3.alpha.,4.alpha.,8.alpha., 9.beta.,11.alpha.,13.alpha.,14.beta.,16.beta.,17z)- but more generally known as fusidic acid, which bears U.S. National Institutes of Health Compound Identifier 3000226.

UNSPSC 51285504 Fusidate or fusidic acid is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal scope. The recent opportunities tagged to this code involve naloxone distribution, emergency medical supplies, generic pharmaceuticals through cooperative purchasing, and direct-to-manufacturer prescription programs—none of which center on fusidate or fusidic acid as an antibiotic product. The mismatch between the code's antibiotic-specific name and the actual solicitations suggests either miscoding by issuing bodies or a data classification artifact; this code does not currently reflect active procurement for the topical antibiotic itself within state and local government channels.

The few opportunities present span diverse issuing bodies and geographies without a coherent pattern tied to fusidate procurement. Seminole County, Florida issued an IFB for naloxone and drug deactivation systems due July 26, 2023; the City of Tampa issued an IFB for medical and first aid supplies with a $700,000 estimated value and a March 13, 2026 deadline; the Texas Health and Human Services Commission issued an RFI on direct-to-manufacturer prescriptions due April 3, 2026; and the Minnesota Multistate Cooperative Purchasing Alliance issued an RFP for generic pharmaceuticals and OTC products due March 26, 2026. The geographic spread—Florida, Texas, Minnesota, and Oregon—reflects only the jurisdictions of these unrelated procurements. Absent reliable recent solicitation activity specifically targeting fusidate or fusidic acid products, this code warrants monitoring for future activity rather than immediate pursuit.